Transcription-coupled repair of DNA-protein crosslinks

Christopher J Carnie1, Stephen P Jackson1, Julian Stingele2

  • 1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Trends in Cell Biology
|December 1, 2024
PubMed

Insights

DNA-protein crosslinks (DPCs) are toxic lesions repaired by a transcription-coupled pathway involving Cockayne syndrome proteins. This pathway

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • DNA-protein crosslinks (DPCs) are harmful DNA lesions implicated in human diseases.
  • DPCs arise from endogenous/environmental factors and enzyme actions, obstructing DNA replication.
  • The impact of DPCs on RNA polymerases was previously unclear.

Purpose of the Study:

  • To investigate the consequences of DPC-induced RNA polymerase blockade.
  • To discover and characterize a transcription-coupled DPC repair pathway.

Main Methods:

  • Utilized novel methodologies for studying DPC repair.
  • Investigated the role of RNA polymerase II (RNAPII) stalling in DPC repair initiation.
  • Examined the involvement of Cockayne syndrome (CS) proteins CSB and CSA.

Main Results:

  • Discovered a transcription-coupled (TC) DPC repair pathway.
  • RNAPII stalling triggers TC-DPC repair.
  • TC-DPC repair involves sequential engagement of CSB and CSA, leading to proteasomal DPC degradation.

Conclusions:

  • TC-DPC repair is a critical pathway for resolving DPC-induced transcription stress.
  • Deficiencies in CSA or CSB impair TC-DPC repair, potentially explaining Cockayne syndrome clinical features.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
36.8K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
12.3K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
30.3K
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
9.8K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K